Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a pilot study to explore the effects of pimavanserin and low-dose quetiapine in subjects with Parkinson\'s disease with neuropsychiatric symptoms.
Epistemonikos ID: c79576800aff0741adaf8547e76a9e2eae912b9e
First added on: May 06, 2024